Filing Details

Accession Number:
0001213900-19-016453
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-21 16:33:04
Reporting Period:
2019-08-20
Accepted Time:
2019-08-21 16:33:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1711754 Inmune Bio Inc. INMB Biological Products, (No Disgnostic Substances) (2836) 475205835
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1767280 Joseph Raymond Tesi C/O Inmune Bio Inc.,
1200 Prospect Street, Suite 525
La Jolla CA 92037
President & Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-20 100 $5.96 1,539,033 No 4 P Direct
Common Stock Acquisiton 2019-08-20 100 $5.96 1,539,133 No 4 P Direct
Common Stock Acquisiton 2019-08-20 100 $5.96 1,539,233 No 4 P Direct
Common Stock Acquisiton 2019-08-20 100 $5.96 1,539,333 No 4 P Direct
Common Stock Acquisiton 2019-08-20 100 $5.96 1,539,433 No 4 P Direct
Common Stock Acquisiton 2019-08-20 100 $5.96 1,539,533 No 4 P Direct
Common Stock Acquisiton 2019-08-20 100 $5.96 1,539,633 No 4 P Direct
Common Stock Acquisiton 2019-08-20 100 $5.96 1,539,733 No 4 P Direct
Common Stock Acquisiton 2019-08-20 100 $5.96 1,539,833 No 4 P Direct
Common Stock Acquisiton 2019-08-20 100 $5.92 1,539,933 No 4 P Direct
Common Stock Acquisiton 2019-08-20 1,000 $6.03 1,540,933 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 20, 2019 in eleven open market transactions.